Compliance requirements have caused pharmaceutical research and development (R&D) and product approval cycles to lengthen. Today's feature blog post looks at how software solutions can help automate and streamline the compliance process, helping to minimize compliance-induced delay factors in bringing new pharmaceuticals to market.

Today's feature article explores the benefits of deploying a process-based governance, risk management, and compliance (GRC) program: ensuring compliance with Section 404 of the Sarbanes-Oxley Act (SOX), reducing the number of control tests that need to be maintained, and quantifying the financial exposure from control exceptions to properly prioritize necessary resource deployment are just a few.

While midsized life sciences companies have all the business requirements and compliance issues that their larger competitors do, they have fewer resources with which to deal with them. Today's feature white paper outlines options midsized life sciences companies have to address these issues as part of an ERP-based solution.